12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga36minutes ago

MediciNova MNOV Settlement; Neurogene NGNE Discontinuation

BioPharmCatalyst44minutes ago

Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings

Benzinga03:31

Neurogene Stock Tanks After Adverse Event In Early-Stage Rett Syndrome Gene Therapy Trial

Benzinga00:25

Neurogene Reports Promising Interim Results for NGN-401 Trial

TipRanks00:09

Neurogene Price Target Raised to $72.00/Share From $45.00 by Leerink Partners

Dow JonesNov 12 22:40 · Ratings